• 제목/요약/키워드: Thymoma

검색결과 149건 처리시간 0.026초

흉선의 신경내분비 종양 (Thymic Neuroendocrine Tumor)

  • 이응배;이상철;박태인;조준용;장봉현;이종태;김규태
    • Journal of Chest Surgery
    • /
    • 제35권4호
    • /
    • pp.325-328
    • /
    • 2002
  • 신경내분비 종양은 매우 드문 흉선 종양으로, Kultschizky 세포에서 유래하는 것으로 흉선종과는 다른 것으로 생각된다. 흥선 신경내분비 종양의 병리학적 진단은 광학 현미경 검사, 면역조직화학 염색 및 전자현미경의 소견을 바탕으로 한다. 흥선 유암종의 약 50%에서 내분비 질환을 가지며, 재발과 흉곽외 전이가 특징적이다. 초발 종양이나 재발의 경우에 외과적 절제가 가장 효과적이라고 생각되나, 항암치료나 방사선 치료의 역할은 분명하지 않다. 최근 외과적 절제가 시행된 흉선 신경내분비 종양을 경험하였기에 여기에 보고한다.

중증 근무력증의 외과적 요법: 10례 보 (Surgical treatment of myasthenia gravis: a report of 10 cases)

  • 조대윤;김용진;김주현
    • Journal of Chest Surgery
    • /
    • 제17권2호
    • /
    • pp.292-298
    • /
    • 1984
  • Myasthenia 8ravis is a disorder of neuromuscular function due to a reduction of available acetylcholine receptors at the neuromuscular junction. Typically, the muscle weakness is worse after effort and improved by rest. In 1939, Blalock and associated reported a case of patient with myasthenia gravis who was successfully treated by thymectomy. Since then, operation has become increasingly important in the management of this disease. From 1968 to 1983, 10 cases of myasthenia gravis were operated at the Department of Thoracic and Cardiovascular Surgery,College of Medicine, Seoul National University. 1.Among 10 cases, 4 were male and 6 were female. 2.Thymectomy was performed in 9 cases, and 1 case of malignant thymoma with deeply infiltration to adjacent structure was not resectable. 3.There was 1 operative mortality with respiratory failure. 4.During follow-up period, most of them showed symptomatic improvement, but complete remission was not noticed in any case.

  • PDF

보험의학적 악성도평가 (Differentiation between malignant and benign in terms of insurance claims)

  • 이신형
    • 보험의학회지
    • /
    • 제32권1호
    • /
    • pp.21-27
    • /
    • 2013
  • In case of neoplasm claims, it is important to make a decision of differentiating malignant and benign. In Korean insurance market, there are many insurance products that cover cancer. In the insurance claims adjustment, differentiation between malignant and benign is according to histologic findings. However there are many neoplasms of bad clinical course in spite of benign histopathologic classification. In this article; astrocytoma, thymoma, gastrointestinal stromal tumor, colonic intramucosal carcinoma, gastric high grade adenoma/dysplasia, carcinoid tumor, MALT lymphoma, revision of Korean Classification of Disease-6th edition, and bladder tumors are reviewed in terms of differentiation between malignant and benign in the insurance claims. It may be helpful for claims staff to review important neoplasms in terms of differentiation between malignant and benign.

  • PDF

종격동에 발생한 골외성 골육종;1례 보고 (Extraskeletal Osteogenic Sarcoma of the Mediastinum; 1 Case Report)

  • 원태희;김주현
    • Journal of Chest Surgery
    • /
    • 제26권5호
    • /
    • pp.413-416
    • /
    • 1993
  • Extraskeletal osteogenic sarcoma is a rare malignant tumor of soft tissue, and its predilection sites are the extremity, retroperitoneum, trunk, and the head and neck area. To our knowledge 5 cases of primary involvement of the mediastinum have been reported. Because of its rarity and difficulty in exact diagnosis preoperatively, we report an extraskeletal osteogenic sarcoma in the anterior mediastinum. The patient was a thirty eight old male. He complained of cough and sputum over 2 months. The chest roentgenogram and the chest MRI[magnetic resonance image] were done and showed anterior mediastinal mass with calcification. Excision of the mass was done under the preoperative impression of thymoma, and the pathologic report was extraskeletal osteogenic sarcoma of the mediastinum.

  • PDF

종격동 종양의 외과적 고찰 (Surgical Analysis of Mediastinal Tumor)

  • 이석재
    • Journal of Chest Surgery
    • /
    • 제26권5호
    • /
    • pp.395-402
    • /
    • 1993
  • For the purpose of evaluation of clinical characteristics and histopathological properties in mediastinal tumor, and to provide the guidelines of surgical management of mediastinal tumor,238 patients with mediastinal tumors treated during the period from January 1983 to December 1991 were reviewed at Seoul National University Hospital. There were 106 males & 132 females, and their ages ranged from 3 months to 73 years, with average 33.6 years. The most frequently encountered tumor site was anterosuperior mediastinum followed by posterior, and middle mediastinum. In the pathological viewpoint, thymoma was the most frequent type followed by neurogenic tumor. 81% of the tumor were benign and 19% were malignant. Half of the malignant tumors were neurogenic tumors. Malignancy rate was high in pediatric patients compared to adults as 40% and 19% respectively. 65% of patients were asymptomatic at diagnosis.There was no operative mortality. Post operative complications were occurred in 35 cases. Most frequent complications were adjacent peripheral nerve injuries. But other usual operative complications, such as bleeding, chylothorax, infection, were relatively rare.

  • PDF

종격동 종양의 임상적 고찰 (Clinical Evaluation of the Mediastinal Tumors and Cysts -26 cases report-)

  • 신호승
    • Journal of Chest Surgery
    • /
    • 제23권4호
    • /
    • pp.745-749
    • /
    • 1990
  • A wide variety of histologically or clinically different tumors and cysts can occur from the many anatomical structures located within the mediastinum. We report the analysis of the 26 cases of mediastinal tumors and cysts, experienced in the Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hallym University from March 1983 to February 1990. Sex ratio of male to female was 1:1.16 and mean age was 33.4 years. Malignant tumors were 8 cases[30.7%], benign tumors were 18 cases[69.2%] The most common histologic types were thymoma, 6 cases[23%] and teratoma, 6 cases [23%] followed by neurogenic tumor, 4 cases[15%] and mediastinal tuberculoma, 3 cases [11.5%]. The most frequent symptoms were chest pain and discomfort. Most of benign tumors were completely removed and malignant tumors were treated with anticancer chemotherapy and radiotherapy after operation. Postoperative complications were developed in 4 cases[15.3%] and hospital mortality was 3.8%.

  • PDF

중증근무력증의 광범위 흉선 절제술 (Extended Thymectomy in Myasthenia Gravis)

  • 조광조
    • Journal of Chest Surgery
    • /
    • 제25권12호
    • /
    • pp.1516-1522
    • /
    • 1992
  • Thirty patients with myasthenis gravis[MG] underwent transternal extended thymectomy between 1983 and 1992 in Pusan National University Hospital. The age of patients was 11 to 62 years[mean; 35.2 years] with female dominant[M: F=l: 4]. According to modified Osserman classification, group I was in 6, II A in 7, II B in 13, III in 2, IV in 2 patients respectively. Their clinical response to thymectomy was evaluated. The follow-up period ranged from 2 months to 9.5 years[average; 51.3 months]. Fourteen patients[13.3%] had remission and eleven[43.3%] were improved after operation; half of patients were benefited from operation. Twenty patients had thymic hyperplasia and seven had non-infiltrating thymoma. In thymomatous MG one patient had remission and five were improved. Postoperative death was in a female patient. The cause of death was respiratory failure in the severe generalized MG preoperatively.

  • PDF

중증 근무력증의 흉선절제술 (Clinical Evaluation of Thymectomy in Myasthenia Gravis)

  • 박창권
    • Journal of Chest Surgery
    • /
    • 제25권8호
    • /
    • pp.844-849
    • /
    • 1992
  • Between 1979 and 1991 thymectomy was performed on 31 patients with myasthenia gravis at the department of thoracic and cardiovascular surgery, Keimyung University medical school. All patients were treated by transsternal thymectomy. During follow-up period that ranged from a month to 10.7 years[mean 2 years], the remission rate for the entire group was 16.1 percent and an additional 71.0 percent had improvement [87.1 percent benefited]. In those 8 patients with thymoma, the remission rate was 12.5 percent with 75.0 percent of the patients benefiting from operations The remainimg 23 patients fared better the operations: 17.4 percent had remission and a total of 91.4 percent benefited. There was no mortality, I concluded that most patients with myasthenia gravis will benefit from thymectomy, and that the improvement persists over an extended period of time in a high percentage of patients.

  • PDF

Acquired myasthenia gravis in a domestic shorthair cat with cranial mediastinal mass

  • Song, Doo-Won;Kang, Min-Hee;Park, Hee-Myung
    • 대한수의학회지
    • /
    • 제56권2호
    • /
    • pp.121-123
    • /
    • 2016
  • A 7-year-old castrated male domestic short-hair cat presented with anorexia, constipation, depression, and voice alteration. Physical and neurological examinations revealed hyperthermia ($40.5^{\circ}C$), ventroflexion of the neck, reduced responses to external stimuli, generalized muscle weakness, and exercise intolerance. Thoracic radiographs revealed the presence of a cranial mediastinal mass. The history, clinical signs, and other examination results were compatible with acquired myasthenia gravis (MG). Acetylcholine receptor (AChR) antibody titers were determined to confirm MG and the serum AChR antibody concentration was 1.24 nmol/L (reference interval, < 0.3 nmol/L). This is the first diagnosis of acquired MG in a cat in Korea.

Streptomyces 배양액에서의 Interleukin-1 유사물질의 동정 (Identification of Interleukin-l Like Material in Streptornyces Culture Supernatant)

  • 남명수;배윤수;윤도영;남경수;최인성;정태화
    • 한국미생물·생명공학회지
    • /
    • 제21권2호
    • /
    • pp.144-149
    • /
    • 1993
  • We have identified a T cell-activating material in the culture supernatant of Streptomyces species. The factor in microbial culture supernatant (MCS) induced thymocyte proliferation in a does dependent fashion and it could be detected by immunoblot analysis using anti-interleukin-1(IL-1) antibody. The factor in MCS was slightly larger(about 21 kd) in its molecular weight than IL-1 on SDS-PAGE. When 125I-MCS was covalently coupled with homo-bifunctional cross-linking agent, disuccinimidyl-propionate to IL-1 receptor(IL-1R) on mouse thymoma cell(EL-4) and immunoprecipitated with anti-IL-1R antibody the molecular weight of this complex of 110 kd was observed.

  • PDF